Concepedia

Matthew L. DuPrie

ML

Statistics

Publications

7

Citations

404

H-Index

7

Active since

2008

Affiliations

Ludwig Cancer Research(Current)

Johnson & Johnson (United States)

University of California San Diego

University of Michigan

Matthew L. DuPrie is an author at Ludwig Cancer Research specializing in molecular oncology, genetics, and cell biology.

Publications per year

2008–2025

7

Publications

7

Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1

Maria E. González, X. Li, Kathy A. Toy et al. · Oncogene · 2008 · 194 citations

, , +12

Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer

Maria E. González, Matthew L. DuPrie, Heather Krueger et al. · Cancer Research · 2011 · 112 citations · Full text

, , +17

Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties

Nilufer P. Seth, Rui Xu, Matthew L. DuPrie et al. · mAbs · 2025 · 30 citations · Full text

, , +17

Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling

Kacey L. Sachen, Deepa Hammaker, Indra Sarabia et al. · Frontiers in Immunology · 2025 · 27 citations · Full text

, , +13

TNFR-Associated Factor 6 and TGF-β–Activated Kinase 1 Control Signals for a Senescence Response by an Endosomal NK Cell Receptor

Sumati Rajagopalan, Elizabeth C. Lee, Matthew L. DuPrie et al. · The Journal of Immunology · 2013 · 14 citations · Full text

, , +15

1–5 of 7